Verastem Inc (VSTM)
9.98
+0.35
(+3.63%)
USD |
NASDAQ |
Apr 30, 16:00
9.98
0.00 (0.00%)
After-Hours: 20:00
Verastem Cash from Investing (Quarterly): 12.44M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.44M |
| September 30, 2023 | -70.08M |
| June 30, 2023 | 14.00M |
| March 31, 2023 | -0.804M |
| December 31, 2022 | 13.02M |
| September 30, 2022 | 4.647M |
| June 30, 2022 | 29.25M |
| March 31, 2022 | 19.26M |
| December 31, 2021 | 0.066M |
| September 30, 2021 | 10.00M |
| June 30, 2021 | 2.393M |
| March 31, 2021 | -12.37M |
| December 31, 2020 | -79.38M |
| September 30, 2020 | -0.006M |
| June 30, 2020 | -0.027M |
| March 31, 2020 | 32.05M |
| December 31, 2019 | 25.13M |
| September 30, 2019 | 17.59M |
| June 30, 2019 | 46.53M |
| March 31, 2019 | 0.363M |
| December 31, 2018 | -126.80M |
| September 30, 2018 | -15.48M |
| June 30, 2018 | -0.53M |
| March 31, 2018 | 4.435M |
| December 31, 2017 | 4.509M |
| Date | Value |
|---|---|
| September 30, 2017 | 21.32M |
| June 30, 2017 | 14.02M |
| March 31, 2017 | 4.096M |
| December 31, 2016 | 0.986M |
| September 30, 2016 | 3.729M |
| June 30, 2016 | 31.11M |
| March 31, 2016 | 1.104M |
| December 31, 2015 | 15.19M |
| September 30, 2015 | -3.791M |
| June 30, 2015 | 8.942M |
| March 31, 2015 | -47.40M |
| December 31, 2014 | 13.48M |
| September 30, 2014 | 7.62M |
| June 30, 2014 | 17.92M |
| March 31, 2014 | 4.118M |
| December 31, 2013 | 2.792M |
| September 30, 2013 | -43.42M |
| June 30, 2013 | -8.012M |
| March 31, 2013 | 25.25M |
| December 31, 2012 | 4.893M |
| September 30, 2012 | 2.109M |
| June 30, 2012 | -4.673M |
| March 31, 2012 | -48.19M |
| December 31, 2011 | -35.88M |
| September 30, 2011 | -0.369M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-79.38M
Minimum
Dec 2020
46.53M
Maximum
Jun 2019
3.353M
Average
10.00M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -1.202B |
| Geron Corp | 47.57M |
| Altimmune Inc | -7.959M |
| Oragenics Inc | -1.00M |
| Actinium Pharmaceuticals Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.68M |
| Cash from Financing (Quarterly) | -0.446M |
| Free Cash Flow | -86.46M |
| Free Cash Flow Per Share (Quarterly) | -1.105 |
| Free Cash Flow Yield | -39.33% |